Rep. Norm Thurston — Voting Record

Utah House District 62 · complete roll-call record from le.utah.gov
← All votes

Bill

Genetic Information Amendments
Number
H.B. 182 (2026GS)
Sponsor
Rep. Brooks, Walt
Final action
Governor Signed 3/17/2026
Outcome
Became law — signed by Gov. Spencer J. Cox

Summary

This bill addresses the use of genetic sequencing tools and the storage of genetic sequencing data.

What it does

  • This bill:
  • defines terms;
  • prohibits the use of certain genetic sequencers and genetic sequencing software;
  • prescribes requirements and restrictions related to the storage of genetic sequencing data;
  • requires relevant entities to certify compliance with genetic sequencing requirements;
  • authorizes the attorney general to investigate alleged violations of genetic sequencing requirements, and initiate civil actions for those violations; and
  • provides protections for an employee who reports a suspected violation of genetic sequencing requirements to the attorney general.

Every vote on this bill

2026-01-22House Comm - Substitute Recommendation
House Economic Development and Workforce Services Committee
8-0-2not eligible / no record
2026-01-22House Comm - Favorable Recommendation
House Economic Development and Workforce Services Committee
8-0-2not eligible / no record
2026-02-03Senate Comm - Substitute Recommendation
Senate Health and Human Services Committee
4-0-3not eligible / no record
2026-02-03Senate Comm - Favorable Recommendation
Senate Health and Human Services Committee
4-0-3not eligible / no record
2026-01-29House/ passed 3rd reading
Senate Secretary
69-0-6YEA
2026-02-05Senate/ substituted
Senate 2nd Reading Calendar
0-0-29not eligible / no record
2026-02-05Senate/ passed 2nd reading
Senate 3rd Reading Calendar
24-0-5not eligible / no record
2026-02-20House/ concurs with Senate amendment
Senate President
67-0-8YEA
2026-02-19Senate/ circled
Senate 3rd Reading Calendar
0-0-29not eligible / no record
2026-02-19Senate/ uncircled
Senate 3rd Reading Calendar
0-0-29not eligible / no record
2026-02-19Senate/ floor amendment
Senate 3rd Reading Calendar
0-0-29not eligible / no record
2026-02-19Senate/ passed 3rd reading
Clerk of the House
26-0-3not eligible / no record

Bill text

enrolled version · official source
5
26B-2-244
26B-2-244
0
Genetic Information Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Walt Brooks
Senate Sponsor: Keven J. Stratton
LONG TITLE
General Description:
This bill addresses the use of genetic sequencing tools and the storage of genetic 
sequencing data.
Highlighted Provisions:
This bill:
defines terms;
prohibits the use of certain genetic sequencers and genetic sequencing software;
prescribes requirements and restrictions related to the storage of genetic sequencing data;
requires relevant entities to certify compliance with genetic sequencing requirements;
authorizes the attorney general to investigate alleged violations of genetic sequencing 
requirements, and initiate civil actions for those violations; and
provides protections for an employee who reports a suspected violation of genetic 
sequencing requirements to the attorney general.
Money Appropriated in this Bill:
None
Other Special Clauses:
This bill provides a special effective date.
Utah Code Sections Affected:
ENACTS:
26B-2-244
, Utah Code Annotated 1953
Be it enacted by the Legislature of the state of Utah:
Section 1. Section 
26B-2-244
 is enacted to read:
26B-2-244
. Genetic sequencing -- Storage of genetic information -- Enforcement.
(1)
As used in this section:
(a)
"DNA" means deoxyribonucleic acid.
(b)
"Domicile" means the country where:
(i)
a company is registered and headquartered;
(ii)
a company's affairs are primarily completed; or
(iii)
the majority of a company's ownership share is held.
(c)
"Foreign adversary" means a foreign adversary identified in 15 C.F.R. Sec. 791.4.
(d)
"Genetic sequencer" means a device or platform used to conduct genetic sequencing, 
resequencing, isolation, or other similar genetic research.
(e)
"Genetic sequencing" means a method to determine the identity and order of 
nucleotide bases in the human genome.
(f)
"Genomic research facility" means a facility that conducts research on, with, or 
relating to genetic sequencing or the human genome.
(g)
"Human genome" means a complete set of nucleic acid sequences for a human, 
encoded as the DNA within each of the 23 distinct chromosomes in the cell nucleus.
(h)
"Medical facility" means a facility for the delivery of health services that:
(i)
receives public funds, including pass-through appropriations from the federal 
government;
(ii)
is registered to provide health care services in the state; or
(iii)
conducts research or testing on, with, or relating to genetic sequencing or the 
human genome.
(i)
(i)
"Open data" means genetic sequencing data that is available in the public 
domain, including in publicly available and open source repositories, databases, or 
publications.
(ii)
"Open data" includes genetic sequencing data derived from standard research cell 
lines.
(j)
"Operational and research software" means a computer program used for the 
operation, control, analysis, or other necessary functions of genetic sequencing or a 
genetic sequencer.
(k)
"Software" means a program or routine, or a set of one or more programs or routines, 
used or intended for use to cause one or more computers or pieces of 
computer-related peripheral equipment, to perform a task or set of tasks related to 
genetic sequencing or a genetic sequencer.
(2)
(a)
A medical facility or genomic research facility may not use a genetic sequencer or 
operational and research software that is a final product produced in or by, or 
distributed by, a foreign adversary, a foreign adversary's state-owned enterprise, a 
person domiciled within a foreign adversary, or an owned or controlled subsidiary or 
affiliate of a person domiciled within a foreign adversary.
(b)
A medical facility or genomic research facility with a genetic sequencer or genetic 
sequencing device prohibited under Subsection 
(2)(a)
 that is not permanently 
disabled shall:
(i)
remove or permanently disable the genetic sequencer or genetic sequencing 
device; and
(ii)
use a genetic sequencer or genetic sequencing device that is not prohibited by 
Subsection 
(2)(a)
.
(3)
(a)
A medical facility, genomic research facility, or other person that stores genetic 
sequencing data may not store the data within the boundaries of a foreign adversary.
(b)
Remote access to genetic sequencing data storage, other than open data, by a person 
within the boundaries of a foreign adversary is prohibited unless approved in writing 
by the department.
(c)
A medical facility, genomic research facility, or other person that stores genetic 
sequencing data other than open data, including through a contract with a third-party 
data storage provider, shall ensure the security of the genetic sequencing data by 
using reasonable encryption methods, restrictions on access, and other cybersecurity 
best practices.
(d)
Genetic sequencing data gathered as part of a clinical trial is exempt from the 
provisions of this Subsection 
(3)
, if the genetic sequencing data is gathered:
(i)
from clinical trial subjects outside the United States; or
(ii)
as part of a clinical trial and the storage, transfer, or remote access to the data is 
otherwise permitted under 28 C.F.R. Part 202.
(4)
(a)
(i)
No later than December 31, 2028, each medical facility and genomic 
research facility that is subject to this section shall provide a sworn statement to 
the attorney general and the department confirming that the medical facility or 
genomic research facility is in compliance with the requirements of this section.
(ii)
Each medical facility and genomic facility that is subject to this section shall 
provide the sworn statement described in Subsection 
(4)(a)(i)
 to the attorney 
general and the department every 10 years.
(b)
A person that violates Subsection 
(2)
 is subject to a fine of $10,000 per violation, 
enforceable beginning May 1, 2028.
(c)
For the purposes of Subsection 
(4)(b)
, each unique instance of a human genome 
undergoing genetic sequencing or analysis using a prohibited genetic sequencer or 
prohibited operational and research software is a separate violation.
(d)
A person that knowingly violates the provisions of Subsection 
(3)(a)
 by storing 
genetic sequencing data within the boundaries of a foreign adversary is subject to a 
fine of $10,000 per violation, enforceable beginning May 1, 2028.
(e)
This Subsection 
(4)
 does not apply to an entity that is subject to Title 13, Chapter 60, 
Part 1, Genetic Information Privacy Act.
(5)
(a)
The attorney general has the sole authority to enforce the provisions of this section.
(b)
Any person may notify the attorney general of a violation or potential violation of 
this section, and the attorney general may investigate an alleged violation of this 
section and institute appropriate actions regarding suspected violations.
(c)
The attorney general may initiate a civil action against a person for violating 
Subsection 
(2)
 or 
(3)
.
(d)
In an action to enforce Subsection 
(2)
 or 
(3)
, the attorney general may recover:
(i)
actual damages;
(ii)
costs;
(iii)
attorney fees; and
(iv)
$10,000 for each violation of Subsection 
(2)
 or 
(3)
.
(6)
An employer may not take an adverse employment action against an employee if:
(a)
the employee notifies the attorney general of a violation or potential violation of this 
section; and
(b)
the adverse employment action is based on the employee notifying the attorney 
general regarding the violation.
(7)
If any provision of this section, or the application of any provision to any person or 
circumstance, is held to be invalid, that holding does not affect the remainder of this 
section or the application of this section's provisions to any other person or circumstance.
Section 2. 
Effective Date.
This bill takes effect on 
January 1, 2028
.
2-24-26 11:55 AM